As Chief Operating Officer at Molecule to Medicine (MTM), Sam Harris is responsible for optimising governance, space, and operations so our biotech teams and companies stay compliant and focused on life-saving science. Her mission is to manage the intersection of corporate governance, strategic space planning, and operations, providing the structural stability required for MTM’s ecosystem to scale. By establishing a rigorous and high-functioning foundation, Sam ensures that operational and scientific experts have the precise information and environments they need to focus exclusively on their core mission: developing groundbreaking medicines.
With a 20-year career providing high-level operational support within the IT and software industries, Sam possesses a unique ability to manage the complexities of rapidly evolving businesses. She specialises in aligning corporate compliance with physical operations, creating a reliable backbone for teams to thrive. Sam holds a BSc (Hons) in International Business and Modern Languages from Aston University and is dedicated to fostering a supportive, high-integrity culture that drives MTM’s long-term success.
